Dr. Aseem Malhotra has built much of his career around asking uncomfortable questions about modern medicine.
As a cardiologist, author, and public health advocate, he has become a prominent critic of the way medical evidence is interpreted and communicated, particularly when it comes to cardiovascular disease. His work has challenged conventional thinking around cholesterol, statins, dietary guidelines, pharmaceutical influence, and what informed consent should actually look like.
That made this a particularly interesting conversation.
When patients receive medical advice, most reasonably assume that the recommendation is based on clear evidence and that they are being given an accurate picture of the potential benefits and risks.
But is that always the case?
I sat down with Aseem to talk about how medical evidence can become distorted, why doctors should be willing to question established practices, and what patients need to understand before making decisions about their health.
We get into cholesterol and statins, the limitations of stents, metabolic health, pharmaceutical influence, COVID vaccine safety, censorship, and a much bigger question underlying all of it:
Watch the full conversation below:
What we get into
- Why Aseem began questioning conventional thinking around cholesterol and cardiovascular disease
- What patients should understand about statins and absolute versus relative risk
- Why stents can be lifesaving in emergencies but may be overused in stable heart disease
- How pharmaceutical industry incentives can influence medical research
- Why metabolic health deserves more attention in cardiovascular care
- Aseem’s changing position on COVID vaccine safety
- Censorship, scientific disagreement, and the importance of physicians being willing to change their minds
Are we treating patients or numbers?
One of the biggest themes in our conversation is something I talk about frequently: a lab value is not a patient.
Modern cardiology places enormous emphasis on LDL cholesterol. If LDL goes down, treatment is often considered successful.
But patients care about much bigger questions.
Will this stop me from having a heart attack? Will it help me live longer? What are the potential downsides?
Aseem explains why examining the evidence around cholesterol and statins caused him to reconsider some of what he had been taught. We also discuss the importance of communicating absolute risk so patients can understand the actual magnitude of benefit they might receive from a treatment.
Patients deserve that information before making a decision.
Heart disease is not a plumbing problem
We also discuss coronary stents.
There are situations where opening a blocked artery can absolutely be lifesaving, particularly during an acute heart attack.
But that does not mean every narrowed artery needs to be opened.
Heart disease is more complicated than plumbing.
Treating one blockage does not necessarily address the underlying conditions that allowed cardiovascular disease to develop in the first place.
That is why prevention requires us to look deeper at metabolic health, insulin resistance, nutrition, inflammation, sleep, activity, and other risk factors.
Fixing an artery is not the same thing as fixing the person.
Can we trust the medical system?
Aseem and I also discuss the relationship between pharmaceutical companies, medical research, clinical guidelines, and practicing physicians.
Most doctors genuinely want to help their patients. But they depend on published research and clinical guidelines to make decisions.
When financial incentives influence how evidence is produced, interpreted, or communicated, those effects can eventually reach the examination room.
This does not require a conspiracy. It requires misaligned incentives.
That is why physicians need to remain willing to examine the evidence themselves, question accepted wisdom, and change their minds when better information becomes available.
What happens when doctors challenge the consensus?
Our conversation eventually moves into one of the most controversial parts of Aseem’s career: his changing position on COVID vaccines.
He explains why he initially supported vaccination, what caused him to reconsider his position, and why he believes emerging safety concerns deserve greater scrutiny.
Whatever your position on COVID vaccines, there is a larger principle worth discussing.
Science needs disagreement.
Medicine progresses when evidence can be questioned and physicians can openly debate competing interpretations of that evidence.
Both Aseem and I entered medicine believing many things we no longer believe today. Our views changed because we continued looking at the evidence and asking questions.
Changing your mind is not a weakness in medicine.
Sometimes, it is exactly what good medicine requires.
Watch the full conversation with Dr. Aseem Malhotra above for our discussion about cholesterol, statins, stents, metabolic health, medical evidence, COVID vaccine safety, and whether patients can trust modern medicine.